Consistent with FDA policy, CuraCloud has enhanced its recently cleared CT triage platform,
CuraRad-ICH, to process chest CT exams.
CuraRad-Pneumonia Triage uses a deep learning-based algorithm for the detection and prioritization of incidental pneumonia findings associated with COVID-19 from non-contrast chest CT images. The results, available to the PACS worklist in less than one minute, can be used to notify the radiology worklist that the image includes findings suggestive of pneumonia associated with COVID-19 so that a radiologist can review sooner and make a definitive report.
As the first wave subsides and COVID-19 cases become less routine, AI algorithms can alert radiologists of suspected incidental pneumonia findings that may be associated with COVID-19 from chest CT scans. This could allow for earlier notification of COVID-19-related findings in otherwise asymptomatic patients.
An integrated clinical workflow in which chest CT images are routed to CuraRad-Pneumonia, where a deep learning neural network can detect suspected incidental pneumonia findings associated with COVID-19. Suspected pneumonia cases can be prioritized on the worklist and flagged for urgent attention. CuraRad-Pneumonia can be seamlessly integrated with worklist applications and PACS/VNA (Vendor Neutral Archives).
What it does
CuraRad-Pneumonia is software that reviews non-contrast chest CT cases and flags those with features consistent with pneumonia findings, including pneumonia that is associated with COVID-19. The software may be activated via an application programming interface (API) from a workflow management system or worklist, such as may exist within a picture archiving and communication system.
Using deep learning techniques, the software analyzes chest CT scans and sends binary prediction results (suspected pneumonia vs. non-suspected pneumonia) to the worklist. The detection results may be used by to alert radiologists that an image includes findings suggestive of pneumonia associated with COVID-19.
Collaborate With Us
We are seeking collaboration partners to further develop our triage portfolio.